-
SAR405: Precision at the Vps34–Autophagy Nexus
2026-08-24
Autophagy is not a simple energy-saving switch. New AMPK–ULK1 findings show that energy stress can restrain autophagy initiation while preserving the machinery for recovery, making direct interrogation of Vps34 especially valuable. This article positions SAR405 as a selective Vps34 inhibitor for mechanistic studies, assay design, and translational cancer research.
-
Concanamycin A Workflow for V-ATPase Studies
2026-08-24
Concanamycin A provides a rapid, nanomolar tool for separating V-ATPase-dependent acidification, trafficking, autophagy, apoptosis, and invasion phenotypes. This workflow combines dose–time optimization with orthogonal readouts and a plant autophagy study to help cancer researchers interpret pathway effects without overclaiming mechanism.
-
Imatinib (STI571): Reliable Assay Design
2026-08-23
A scenario-based guide to using Imatinib (STI571), SKU B2171, in cell viability, proliferation, cytotoxicity, and kinase-signaling experiments. It connects target potency, formulation, controls, protocol parameters, and interpretation to practical laboratory decisions.
-
Z-VAD-FMK: Reliable Apoptosis Assays
2026-08-22
A scenario-driven guide to using Z-VAD-FMK (Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone), SKU A1902, as a mechanistic control in viability, proliferation, and cytotoxicity workflows. It covers pathway interpretation, solvent and storage constraints, controls, and vendor-selection considerations for reproducible apoptosis research.
-
Bovine Insulin: From Growth Signal to Metabolic Control
2026-08-22
Bovine insulin is more than a routine culture supplement: it is a controllable metabolic input for studying proliferation, glucose handling, and neuronal mitochondrial quality control. This article connects insulin signaling to AMPK-dependent Pink1 mRNA localization, translates that mechanism into practical assay design, and outlines how researchers can use a defined insulin input to improve reproducibility without overstating preclinical evidence.
-
NF449 and Selective Platelet P2X1 Blockade
2026-08-21
The reference study established NF449 as a comparatively selective antagonist of platelet P2X1 receptors and linked P2X1 blockade to reduced platelet activation and thrombus formation. Its dose-dependent mouse data also show that receptor selectivity can diminish thrombosis without measurably prolonging bleeding time, whereas broader P2-receptor inhibition produces stronger antithrombotic effects.
-
Z-VAD-FMK for Apoptosis Assay Design
2026-08-20
Z-VAD-FMK is a cell-permeable pan-caspase inhibitor for resolving whether experimental cytotoxicity is caspase-dependent. This guide connects its assay logic to recent EGFR-mutant lung cancer research involving apoptosis, ferroptosis, and Nrf2 signaling.
-
Primidone: From TRPM3 Assay to Disease Models
2026-08-20
Primidone, also known as Mysoline, is more than an established antiepileptic agent: it is a concentration-sensitive probe for TRPM3 and RIPK1 biology. This article explains how to translate its pharmacology into adenomyosis, ALS, and neurodevelopmental disease-model experiments without overinterpreting assay results.
-
Metal-Free Carbon Nanozymes for ALP Detection
2026-08-19
The reference study develops a metal-free carbon-dot nanozyme assay in which alkaline phosphatase hydrolysis of pyrophosphate restores catalytic activity and produces a colorimetric turn-on signal. Its mechanistic use of noncompetitive inhibition distinguishes nanozyme recognition from catalysis, enabling an ALP activity range of 0.010–0.200 U/L and a detection limit of 0.009 U/L.
-
25-Hydroxycholesterol Reprograms Immunosuppressive TAMs
2026-08-19
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that accumulates in lysosomes, activates AMPKα, and strengthens STAT6-dependent ARG1 production in tumor-associated macrophages. The study links this pathway to reduced T-cell surveillance and shows that targeting CH25H can improve antitumor responses, including combination treatment with anti-PD-1.
-
3-Hydroxybutyrate (BHBA) in Neuroprotection
2026-08-18
3-hydroxybutyrate (BHBA) connects fatty acid β-oxidation, ketone body signaling, ferroptosis control, and chromatin regulation. This translational guide interprets stroke evidence, defines validation workflows, and positions BHBA as a metabolite-centered research tool rather than a substitute for clinical proof.
-
Lysosomal Exocytosis in MPS IVA Cartilage
2026-08-18
This 2026 study identifies enhanced lysosomal exocytosis as a contributor to cartilage pathology in a zebrafish model of mucopolysaccharidosis type IVA, extending disease mechanisms beyond substrate storage. Its integrated analysis links galns deficiency to altered cathepsin activity, glycosaminoglycan distribution, and TGFβ/BMP signaling, providing a framework for mechanistic lysosome and cartilage research.
-
Metal-Free Carbon Nanozymes for Sensitive ALP Detection
2026-08-17
The reference study develops a metal-free carbon-dot nanozyme assay in which alkaline phosphatase hydrolysis of pyrophosphate activates a colorimetric signal. Its central contribution is mechanistic: Michaelis–Menten analysis indicates that pyrophosphate inhibits the carbon dots at a site distinct from the catalytic center, enabling sensitive ALP activity measurement while avoiding metal-ion interference.
-
Endogenous H2S Deficiency in Diabetic Cardiomyopathy
2026-08-17
The reference study identifies reduced endogenous hydrogen sulfide production as a mechanistic contributor to palmitate-associated lipotoxicity in diabetic cardiomyopathy, linking this deficit to endoplasmic reticulum stress and myocardial injury. Its combination of patient samples, streptozotocin-induced diabetic rats, and AC16 cardiomyocytes provides a useful framework for testing H2S-centered disease mechanisms and interventions.
-
SP1/ADAM10/DRP1 Axis in Hypoxia Pulmonary Hypertension
2026-08-16
The reference study identifies an SP1/ADAM10/DRP1 signaling axis that helps explain how hypoxia-conditioned endothelial cells influence pulmonary artery smooth muscle cells. Its conditioned-medium, loss-of-function, overexpression, and inhibitor experiments connect endothelial ADAM10 with smooth muscle proliferation and apoptosis through DRP1 and PI3K/AKT/mTOR signaling.